Atherosclerosis
Volume 209, Issue 1 , Pages 74-80 , March 2010

Vaccination against Foxp3+ regulatory T cells aggravates atherosclerosis

  • T. van Es

      Affiliations

    • Division of Biopharmaceutics, Leiden University, Leiden, The Netherlands
    • These authors contributed equally.
    • ,
  • G.H.M. van Puijvelde

      Affiliations

    • Division of Biopharmaceutics, Leiden University, Leiden, The Netherlands
    • These authors contributed equally.
    • Corresponding Author InformationCorresponding author at: LACDR, Div. of Biopharmaceutics, Gorlaeus Laboratories, Einsteinweg 55, PO Box 9502, 2300 RA Leiden, The Netherlands. Tel.: +31 71 5276051; fax: +31 71 5276032.
    • ,
  • A.C. Foks

      Affiliations

    • Division of Biopharmaceutics, Leiden University, Leiden, The Netherlands
    • ,
  • K.L.L. Habets

      Affiliations

    • Division of Biopharmaceutics, Leiden University, Leiden, The Netherlands
    • ,
  • I. Bot

      Affiliations

    • Division of Biopharmaceutics, Leiden University, Leiden, The Netherlands
    • ,
  • E. Gilboa

      Affiliations

    • Department of Surgery, Duke Center for Translational Research, Durham, NC, United States
    • ,
  • T.J.C. Van Berkel

      Affiliations

    • Division of Biopharmaceutics, Leiden University, Leiden, The Netherlands
    • ,
  • J. Kuiper

      Affiliations

    • Division of Biopharmaceutics, Leiden University, Leiden, The Netherlands

Received 24 July 2009 ,Revised 20 August 2009 ,Accepted 21 August 2009.

References 

  1. Hansson GK, Robertson AK, Soderberg-Naucler C. Inflammation and atherosclerosis. Annu Rev Pathol. 2006;1:297–329
  2. Benagiano M, Azzurri A, Ciervo A, et al. T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions. PNAS. 2003;100:6658–6663
  3. Frostegard J, Ulfgren AK, Nyberg P, et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis. 1999;145:33–43
  4. Davenport P, Tipping PG. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol. 2003;163:1117–1125
  5. King VL, Szilvassy SJ, Daugherty A. Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor−/− mice. Arterioscler Thromb Vasc Biol. 2002;22:456–461
  6. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4:330–336
  7. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–1061
  8. Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol. 2007;8:191–197
  9. Malek TR, Yu A, Vincek V, Scibelli P, Kong L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity. 2002;17:167–178
  10. van Puijvelde GH, Hauer AD, de Vos P, et al. Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis. Circulation. 2006;114:1968–1976
  11. van Puijvelde GH, van Es T, van Wanrooij EJ, et al. Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27:2677–2683
  12. Maron R, Sukhova G, Faria AM, et al. Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation. 2002;106:1708–1715
  13. George J, Yacov N, Breitbart E, et al. Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein I. Cardiovasc Res. 2004;62:603–609
  14. Harats D, Yacov N, Gilburd B, Shoenfeld Y, George J. Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. J Am Coll Cardiol. 2002;40:1333–1338
  15. Mallat Z, Gojova A, Brun V, et al. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation. 2003;108:1232–1237
  16. Ait-Oufella H, Salomon BL, Potteaux S, et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med. 2006;12:178–180
  17. Nair S, Boczkowski D, Fassnacht M, Pisetsky D, Gilboa E. Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity. Cancer Res. 2007;67:371–380
  18. Nair S, Boczkowski D, Moeller B, Dewhirst M, Vieweg J, Gilboa E. Synergy between tumor immunotherapy and antiangiogenic therapy. Blood. 2003;102:964–971
  19. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal Biochem. 1987;162:156–159
  20. Mallat Z, Ait-Oufella H, Tedgui A. Regulatory T cell responses: potential role in the control of atherosclerosis. Curr Opin Lipidol. 2005;16:518–524
  21. Shibata K, Yamada H, Nakamura R, Sun X, Itsumi M, Yoshikai Y. Identification of CD25+ gammadelta T cells as fetal thymus-derived naturally occurring IL-17 producers. J Immunol. 2008;181:5940–5947
  22. Becknell B, Caligiuri MA. Interleukin-2, interleukin-15, and their roles in human natural killer cells. Adv Immunol. 2005;86:209–239
  23. Driesen J, Popov A, Schultze JL. CD25 as an immune regulatory molecule expressed on myeloid dendritic cells. Immunobiology. 2008;213:849–858
  24. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 2004;303:1529–1531
  25. Heil F, Hemmi H, Hochrein H, et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 2004;303:1526–1529
  26. Lund JM, Alexopoulou L, Sato A, et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci USA. 2004;101:5598–5603
  27. Weck MM, Grunebach F, Werth D, Sinzger C, Bringmann A, Brossart P. TLR ligands differentially affect uptake and presentation of cellular antigens. Blood. 2007;109:3890–3894

PII: S0021-9150(09)00703-5

doi: 10.1016/j.atherosclerosis.2009.08.041

Atherosclerosis
Volume 209, Issue 1 , Pages 74-80 , March 2010

Article Tools

* Image Usage & Resolution